| Option | Typical monthly cost (no insurance) | FDA status | Insurance coverage |
|---|---|---|---|
| Branded GLP-1 (Wegovy, Ozempic, Zepbound, Mounjaro) | $900–$1,300+ | FDA-approved finished drug | Sometimes (prior auth required; diagnosis-dependent) |
| Compounded semaglutide (licensed US 503A pharmacy) | $149–$350 | Not FDA-approved (compounded) | Generally not covered |
| Compounded tirzepatide (licensed US 503A pharmacy) | ~$200–$350 | Not FDA-approved (compounded) | Generally not covered |
Prices are approximate ranges based on publicly available provider pricing. Individual costs vary by dose and provider. Consult fees and lab costs may apply separately.
How much do branded GLP-1 medications cost without insurance?
Branded GLP-1 injectable medications carry list prices that most uninsured patients cannot afford. The published list prices for the major branded injectable GLP-1 products used for weight management have routinely exceeded $1,000 per month. Even after manufacturer savings programs, the monthly cost for patients without commercial insurance — or for those on government programs who are excluded from manufacturer discount programs — can be prohibitive.
Insurance coverage for weight management medications has been inconsistent. Medicare did not historically cover weight management drugs, though this has been an active policy area. Medicaid coverage varies by state. Many commercial plans cover GLP-1 agonists only for specific indications (type 2 diabetes in particular, not weight management), and prior authorization requirements add further friction.
The result: a significant share of patients who could clinically benefit from GLP-1 weight management support are priced out of the branded product market without insurance.
Is compounded GLP-1 a legal, affordable alternative?
Compounded semaglutide and tirzepatide are prepared by licensed 503A compounding pharmacies in the United States to a clinician’s prescription. They are not FDA-approved drug products — they are compounded medications, which means they differ from the branded formulations in their regulatory status. But they use the same active molecules and are compounded under the quality and sterility standards that 503A pharmacies are required to meet.
No hidden overseas supply chain. The pharmacies compounding these medications are licensed US facilities, not international operations of uncertain quality. This distinction is clinically meaningful: purity, potency, and sterility standards at a licensed US 503A pharmacy are not the same as what you get from an overseas vendor or a gray-market research chemical supplier.
The cost difference is substantial. Compounded semaglutide and tirzepatide through legitimate telehealth providers typically run significantly less than branded alternatives — often in the range of $149–$350 per month depending on dose and provider, though specific pricing varies. This is a real difference in monthly out-of-pocket cost that makes clinician-supervised GLP-1 support accessible to patients who are priced out of the branded market.
What goes into the total cost of online GLP-1 support?
The medication price is one line item. Patients evaluating total cost should understand the other components:
- Clinician consultation fee — a legitimate provider requires clinical evaluation before prescribing. This is not a box-checking exercise; it is the clinical review that establishes whether GLP-1 support is appropriate for you, at what dose, with what monitoring. Consultation fees vary by provider.
- Lab costs — some providers include baseline lab costs in their program fee; others require you to get labs separately. Basic metabolic screening before starting GLP-1 therapy is standard and clinically appropriate, not an upsell.
- Ongoing monitoring check-ins — follow-up clinician visits are part of a well-managed protocol. Dose titration, side effect management, and response assessment require clinical engagement over time, not a set-and-forget prescription.
- Supplies — subcutaneous injections require syringes or insulin pen-tip needles and alcohol wipes. These are low-cost but worth including in the total picture.
A provider that advertises a very low per-month medication price but charges separately for everything else, or one that skips clinical evaluation to offer a lower entry price, is not necessarily the better deal. The value of a GLP-1 protocol comes from the combination of an appropriate medication at the right dose with clinical oversight — not just from the drug alone.
What should you look for — and avoid — when evaluating cost?
The expanded availability of compounded GLP-1 has also attracted providers with lower quality standards. When comparing options, these factors matter:
Verified US 503A pharmacy sourcing
Ask specifically where the medication is compounded. A licensed US 503A compounding pharmacy is a defined regulatory category with quality and sterility requirements. “Compounded in the USA” should mean a licensed 503A facility — not a packaging operation that sources active pharmaceutical ingredients from overseas. No hidden overseas supply chain is a meaningful distinction, not a marketing tagline.
Clinical evaluation, not prescription vending
GLP-1 receptor agonists are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Pancreatitis history and certain cardiovascular conditions require evaluation. A provider that skips clinical review to offer faster or cheaper access is skipping the part that keeps patients safe.
Transparent compounded status
Compounded semaglutide and tirzepatide are not FDA-approved drug products. A legitimate provider is transparent about this. Any provider claiming their compounded product is FDA-approved is either confused or misleading you. “Same active ingredient” comparisons to branded products (Ozempic, Wegovy, Mounjaro, Zepbound) are accurate — but compounded products are not the same products, and should not be represented as such.
What is the cost of not treating excess weight?
Excess weight is associated with increased risk across multiple health domains, including cardiovascular disease, metabolic dysfunction, musculoskeletal stress, and sleep quality. The direct and indirect costs of untreated obesity over time — including medical costs for associated conditions — are substantial and underappreciated in point-in-time cost comparisons.
This is not a reason to overpay or to use a provider who cuts clinical corners. It is a reason to evaluate the cost of GLP-1 weight management support in a realistic framework: as a long-term health investment with a real evidence base, not as an optional expense to minimize at all costs.
Frequently asked questions
How much do branded GLP-1 medications cost without insurance?
Branded GLP-1 injectable medications carry list prices that can exceed $1,000 per month without insurance or manufacturer coupons. Even with manufacturer savings programs, out-of-pocket costs vary widely and eligibility is not universal — patients on government insurance programs are often excluded from manufacturer discount programs.
Is compounded GLP-1 legal?
Yes. Compounded semaglutide and tirzepatide are legal to prescribe and dispense through licensed 503A compounding pharmacies when prescribed by a licensed clinician. The FDA has allowed compounding during declared shortages of the branded products under specific conditions. Patients should verify that their provider works with a licensed 503A pharmacy — not an overseas supplier or gray-market vendor.
How much does compounded GLP-1 cost without insurance?
Compounded semaglutide and tirzepatide from licensed 503A pharmacies are substantially less expensive than branded products. Typical monthly costs through legitimate telehealth providers range from roughly $149 to $350 per month depending on dose and provider, though prices vary. This includes the medication itself; a clinician consultation fee may apply separately.
Does insurance cover compounded GLP-1?
Insurance coverage for compounded medications is generally limited or absent. Insurance plans that cover weight management medications typically cover the branded FDA-approved products, not compounded alternatives. For most patients using compounded GLP-1 through a telehealth provider, the expectation is out-of-pocket payment.
Is compounded GLP-1 the same as branded Ozempic or Wegovy?
Compounded semaglutide uses the same active molecule — semaglutide — but it is not the same product as Ozempic or Wegovy. Compounded products are prepared by licensed 503A pharmacies to a clinician's prescription and are not FDA-approved drug products. The active ingredient, dose, and administration route may be similar, but the formulation, delivery system, and manufacturing standards differ.
What should I look for in a legitimate compounded GLP-1 provider?
Key markers of a legitimate provider: works with a licensed US 503A compounding pharmacy (not overseas suppliers), requires a clinical evaluation and labs before prescribing, provides ongoing clinician monitoring, and is transparent about the compounded (not FDA-approved) nature of the product. Avoid providers that skip clinical evaluation or claim their compounded product is FDA-approved.